Log in to save to my catalogue

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with...

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ffd2de004ae43a88d0d80471b9998d6

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

About this item

Full title

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Pharmacogenomics and personalized medicine, 2017-01, Vol.10, p.209-215

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Antipsychotic action of haloperidol is due to blockade of D
receptors in the mesolimbic dopamine pathway, while the adverse drug reactions are associated with striatal D
receptor blockade. Contradictory data concerning the effects of genetic polymorphisms of genes encoding these receptors and associated structures (catechol-O-methyltransferas...

Alternative Titles

Full title

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ffd2de004ae43a88d0d80471b9998d6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ffd2de004ae43a88d0d80471b9998d6

Other Identifiers

ISSN

1178-7066

E-ISSN

1178-7066

DOI

10.2147/PGPM.S140700

How to access this item